Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Clinical trial NCT07104812 · RECRUITING

Trial details

NCT number: NCT07104812
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Autonomous Cortisol Secretion Autonomous Cortisol Secretion (ACS)

Start date: 2026-01-14
Primary completion: 2027-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.